Commercialization is as unique and varied as the therapy under development, involving many critical stages and steps. Our team is expert at turning strategy into tactical action. They are seasoned medical research and pharma industry professionals skilled in spearheading the vision, strategy, and delivery of global tactical programs for treatments of diseases. They use their extensive experience of leading cross-functional teams spanning R&D, medical affairs, and marketing and sales to drive pre- and post-launch commercial strategy and tactics for a wide range of products including small molecules and biopharmaceuticals.
They bring a wealth of experience in managing large budgets and overseeing commercial analytics, market access, medical affairs, and life-cycle strategies and tactics on a global scale, leading to the formulation of evidence plans and development strategies for early stage assets. With deep expertise in the commercial assessment of in-licensing opportunities for medicines and medical technologies, our world-class team is adroit in due diligence and business development activities as well as in mobilizing, supporting, and leading strategic partnerships.
Ready for strong leadership from proven experts in the commercialization? Contact us.